Hum Reprod 2010;25:253264
On the other hand, GLP-2 analogs due to their effects on crypt cell proliferation, improving intestinal expansion and nutrient absorption, are used for intestinal injury and short bowel syndrome (Litvak et al
Yet, medications like Wegovy and Ozempic, which could help address these issues, remain priced at over $1,300 per month, putting them out of reach for millions who need them most (CDC, 2024)
Close to 26% of the physicians on the list were part of the Wellstar Health System enterprise, totaling 130 doctors across the majority of categories
Key updates include: Annual screening for overweight and obesity Confirmation of excess adiposity beyond BMI when feasible Clear recognition that 57% weight loss improves glycemia and cardiometabolic risk Importantly, pharmacologic obesity treatment now emphasizes: Individualized dose titration Balancing efficacy with tolerability Considering alternative agents when response plateaus GLP-1 receptor agonists and dual GIP/GLP-1 therapies now sit at the center of metabolic care